Clinical data requirements for Class II medical devices in Taiwan include providing evidence of safety and efficacy through clinical evaluation reports. Manufacturers must submit data from relevant studies that demonstrate the device’s performance under intended conditions of use. This data must comply with applicable regulatory standards and be supported by robust documentation for TFDA review.